Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 17149

AbstractMaterial and MethodsResultsDiscussionReferencesTable and Figures
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2008 | Month : October | Volume : 2 | Issue : 5 | Page : 1052 - 1056

Serum Paraoxonase Activity In Normolipidaemic Patients With Acute Myocardial Infarction

KUMAR A *,SIVAKANESAN R **,NAGTILAK S***

Department of Biochemistry Manipal College of Medical Sciences Deep Heights, Pokhara, Nepal

Correspondence Address :
Dr. Arun Kumar Department of Biochemistry Manipal College of Medical Sciences Deep Heights, Pokhara, Nepal email:arun732003@gmail.com

Abstract

Background: Although studies have demonstrated that HDL-C associated paraoxonase is involved in protection of LDL-cholesterol and other lipoproteins from the deleterious effects of oxygen free radicals in ischaemia and reperfusion, there are controversial data on the correlation between paraoxonase activity and the ischaemia process.
Aim: The present study was planned to evaluate the paraoxonase activity in patients with acute myocardial infarction (AMI), with normal lipid profile.
Setting and Design:Serum paraoxonase activities were determined in 165 normolipidaemic patients diagnosed with AMI, and 165 age and sex matched healthy volunteers served as controls.
Material and Methods: Serum Paraoxonase activities were measured by using an enzymatic kit manufactured by the Zeptomatrix Corporation, New York, USA, for AMI patients and controls. Also, the lipid profile was analyzed enzymatically in these subjects.
Statistics: The values were expressed as means ± standard deviation (SD), and data from patients and controls was compared by using student’s ‘t’-test.
Results and Conclusion: Serum paraoxonase activity was significantly decreased in AMI patients as compared to controls (p<0.001). Also, total cholesterol levels, TC/ HDL-C ratio, triglyceride levels, LDL-cholesterol levels, LDL-C/ HDL-C ratio and TG/HDL-C ratio were significantly higher (p<0.001), and HDL-cholesterol levels were significantly lower in AMI patients (p<0.001). No correlation was observed between PON1 activity and HDL-C levels in patients and controls. These findings suggest that decreased paraoxonase activity could be due to increased oxidative stress in AMI.

Keywords

Acute Myocardial Infarction, Normal Lipid Profile, Paraoxonase

Introduction
With the explosive rise in the incidence of Coronary Artery disease (CAD), it is estimated that this will be the leading cause of morbidity and mortality in the developing world by the year 2015(1). People hailing from the Indian subcontinent have a higher probability of death due to CAD. It is a multifactorial disease, and some predisposing factors are heredity, hyperlipidaemia, obesity, hypertension, environmental factors and life style variables like stress, smoking, alcohol consumption, etc(2).Diet, especially fat, plays an important role the development of CAD, and the risk further increases in the presence of dyslipidaemia. The lipoprotein profile has been investigated extensively in recent years, which is found to be deranged in a large proportion of CAD patients; especially in Asians showing a mixed picture of dyslipidaemia. Low density lipoprotein cholesterol (LDL) is considered as the most important risk factor of CAD. However, a significant proportion of patients have a normal lipid profile (3). The oxidation of LDL is believed to have a central role in atherogenesis. Subendothelial accumulation of foam cells plays a key role in the initiation of atherosclerosis. These foam cells, which may be generated by the uptake of oxidized LDL by macrophages via scavenger receptors, accumulate in fatty streaks that evolve to more complex fibro fatty or atheromatous plaques(4). Oxidized LDL may also be involved in atherogenesis by inducing smooth muscle cell proliferation(5). and smooth muscle foam cell generation. Under oxidative stress, not only LDL, but other serum lipids are exposed to oxidation. High density lipoprotein (HDL) is one of the most important independent protective factors for arteriosclerosis, which underlies coronary heart disease (CHD). The HDL associated Paraoxonase (PON1) enzyme is known to have protective effects on lipid peroxidation(6).Numerous cohort studies and clinical trials have confirmed the association between a low HDL-cholesterol concentration and an increased risk of CHD. Though many factors may play a role in its pathogenesis, low PON1 activity could be an independent risk factor(7). PON1 activity is inversely related to the risk of developing an atherosclerotic lesion, which contains cholesterol-loaded macrophage foam cells. Although experimental studies have demonstrated the reduction in PON1 activity due to oxygen free radicals in ischaemia and reperfusion(8), there are controversial data on correlation between PON1 HDL-C and the ischaemia process. As it is well established that dyslipidaemia is an important contributory factor for AMI, and PON1 activity is decreased in dyslipidaemia, and so the present study was undertaken with the objective of studying the PON1 activity in normolipidaemic AMI patients, and also to observe whether PON1 activity could be an independent risk factor in this group of subjects.

Material and Methods

One hundred sixty five patients (males 123; females 42) with AMI and 165 age-sex matched healthy volunteers were taken for this study. The study was conducted for a period of four and half years, from April 2002 to August 2006. Informed consent was taken. Smoking habits, systolic and diastolic blood pressure, and family history of coronary heart diseases were recorded after clinical confirmation of AMI.

Diagnostic Criteria of Patients
All the patients had their first episode of MI with diagnostic criteria: typical chest pain, specific abnormalities for MI on electrocardiogram, elevated serum creatine phosphokinase (CPK-MB) and aspartate aminotransferase enzyme levels.

Exclusion Criteria
Patients with diabetes mellitus, renal insufficiency, hypertension, current smokers, hepatic disease, or taking lipid lowering drugs or antioxidant vitamin supplements were excluded.

Criteria for Normolipaedemics
Normal lipid profile was defined if LDL was <130mg/dl, HDL was ≥ 35 mg/dl, Total cholesterol (TC) was <200 mg/dl and Triglycerides (TG) were <150 mg/dl(9).

Venous blood was collected after overnight fasting, EDTA was added, and samples were processed for lipid profiles.
For PON1 activity studies, blood samples were collected from patients who were admitted in the Intensive Care Unit, 4-6 hours after onset of AMI. Only normolipidaemic AMI patients were included in the study. Lipid profile (Total cholesterol, triglycerides, and HDL-cholesterol) were analyzed enzymatically using a kit obtained from (Randox Laboratories Limited, Crumlin, UK). Plasma LDL-cholesterol was determined from the values of total cholesterol and HDL-cholesterol using the following formula:
LDL-c = TC - TG – HDL-c (mg/dl)
For PON1 studies, an assay kit manufactured from Zeptometrix Corporation 872 Main Street, Buffalo New York 14202 (ZMC catalogue 0801199), was used(10),(11). This assay is based on the principle that PON1 catalyzes the cleavage of phenyl acetate, resulting in phenol. The rate of formation of phenol is measured by monitoring the increase in absorbance at 270 nm, at 25°C. One unit of arylesterase activity is equal to 1 µM of phenol formed per minute. The activity is expressed in kU/L, based on the extinction coefficient of phenol of 1310 M-1cm-1 at 270 nm at pH 8.0 and at 25 °C. Blank samples containing water were used to correct for non-enzymatic hydrolysis.

STATISTICAL ANALYSIS
Data on lipid profile and PON1 activity was entered in Microsoft excel for Windows 2000. The mean ± SD was obtained using excel software. The two-sample-t-test value was obtained between the patients and the control. The distribution of ‘t’ probability was calculated depending on ‘n’, and the significance of the test was obtained. P values <0.001 were considered as highly significant.

Results

PON1 activity was significantly decreased in patients with AMI as compared to controls [Table/Fig-1], [Table/Fig-2] and [Table/Fig-3] (p<0.001). Total cholesterol levels, TC/ HDL-C ratio, triglyceride levels , LDL-cholesterol levels, and LDL/ HDL-C ratio, were higher in AMI subjects as compared to controls (Table/Fig 1), (p<0.001). Also, significant differences were seen in HDL-C levels between AMI patients and controls (p<0.001). Total cholesterol levels, TC/ HDL-C ratio, and triglyceride levels were higher in both genders of AMI subjects as compared to controls (Table/Fig 2)and(Table/Fig 3)(p<0.001).Significant differences were seen in the HDL-C levels between AMI patients and controls, only in females(Table/Fig 3) (p<0.001). No correlation was observed between PON1 and HDL-C levels in patients and controls. LDL-cholesterol levels and LDL/ HDL-C ratio were higher in male AMI subjects as compared to controls (Table/Fig 2) (p<0.001)

Discussion

Involvement of oxygen free radicals (OFRs) in the pathophysiology of inflammation, ischaemia and reperfusion causing damage in tissues and organs, have been reported earlier(12).Indirect evidence of OFR generation in AMI patients is substantiated by measuring PON1 activity in them (13), and lowering of PON1 activities in AMI patients have been reported earlier(14),(15).Decrease in PON1 activity could be due to the overwhelming production of OFRs at the time of infarction. Diabetes is one of the major risk factors of AMI, as lowering of PON1 activities are observed in diabetic patients. The lack of protective effect of the PON1 enzyme on OFR’s, aggravates the risk of Coronary Artery Disease in diabetes(16). Reduction in infarct size in animal models of temporary coronary artery occlusion and reperfusion has been tried by various means of anti-free radical interventions(17).Increased OFRs generated in the early stage of MI causes decreased PON1 activity during that phase(18).In the present study, lower PON1 activities were observed in patients as compared to controls. Decreased PON1 activities might be due to enhanced protection from free radical damage in AMI during the ischaemic process. Due to increased production of toxic free radicals, the efficiency to hydrolyze lipid peroxides by PON1 is lowered, which further decreases its specific activity, and the same were observed in the present study. Despite data linking OFR generation in reperfusion injury, scientific studies failed to prove the beneficial effect of oxygen radical scavengers or other agents on infarct size reduction(19).The present study has its limitations, as the study was conducted only on normolipidaemic AMI patients. If the PON1 activity was compared between normolipidaemic and dyslipidaemic AMI patients, then it could have been better to draw a conclusion as an independent risk factor in normolipidaemic patients, and whether there is a significant change in PON1 activities between those two groups. The decreased enzymatic antioxidants could be a compounding factor, predisposing lowered PON1 activities in AMI patients. One might even ponder that the decreased activity of PON1 might be due lower HDL levels, as PON1 is associated with HDL, but the prediction can be over ruled as the present study didn’t observe any correlation between HDL and PON1 activities. The study concludes that due to overwhelming production of free radicals, there is a decreased activity of PON1, and due to its incapability to scavenge free radicals, AMI patients become more susceptible to infarction. As PON1 is associated with HDL, and as it breaks down lipid peroxides and free radicals associated with the lipoprotein, so its activity must be intact, acting as the first line of defense against the oxidized LDL molecules which is the known cause of atherosclerosis. If PON1 activities were normal in these normolipidaemic AMI patients, the probability of infarction could be decreased or delayed. Future research could be carried out on oxidative stress parameters, PON1, and inflammatory markers in both normolipidaemic and dyslipidaemic AMI patients. Measurement of PON1 activities at the baseline after two days and few months after infarction is necessary to arrive at the final conclusions about the role of PON1 in AMI.

References

1.
Reddy KS. Cardiovascular disease in India. World Health Stat Q 1993; 46:101-7.
2.
Chopra V, Wasir H. Implications of lipoprotein abnormalities in Indian patients. Journal Assoc Physicians of India 1998; 46:814-18.
3.
Vasisht S, Narula J, Awtade A, Tandon R, Srivastava LM. Lipids and lipoproteins in normal controls and clinically documented coronary heart disease patients. Ann Natl Acad Med Sci (India) 1990; 26:57-66.
4.
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801–9.
5.
Paul H, Johan V, Stefaan J, Frans Van de W, Désiré C. Oxidized LDL and Malondialdehyde-Modified LDL in Patients with Acute Coronary Syndromes and Stable Coronary Artery Disease. Circulation 1998; 98:1487-94.
6.
Singh S, Venketesh S, Verma JS, Verma M, Lellamma CO, Goel RC. Paraoxonase(PON11) activity in north west Indian Punjabis with coronary artery disease & type II diabetes mellitus. Indian J Med Res 2007; 125:783-87.
7.
Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. Atherosclerosis: basic mechanisms. Oxidation. Inflammarion, and genetics. Circulation 1995; 91:2488-96.
8.
Gur M, Aslan M, Yildiz A, Demirbaq R, Yilmaz R, Selek S, Erel O, Ozdoqru I. Paraoxonase and Arylesterase activities in Coronary Artery disease. Eur J Clin Invest 2006; 36:779-87.
9.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert panel on Detection, Evalation, and treatment of high Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001; 285(19):2486-97.
10.
Lorentz K, Flatter B, Augustin E. Arylesterase in Serum: Elaboration and Clinical application of a Fixed- Incubation Method. Clin Chem 1979; 25: 1714-20.
11.
Haagen L, Brock A. A new automated method of Phenotyping Arylesterase (EC 3.1.1.2) Baased UPON1 Inhibition of Enzymatic Hydrolysis of 4-Nitrophenol Acetate by Phenyl Acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391-95.
12.
Tartan Z, Orhan G, Kasikçioglu H, Uyarel H, Unal S, Ozer N, Ozay B, Ciloglu F, Cam N. The role of paraoxonase (PON1) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients. Heart Vessels 2007; 22:158-1564.
13.
Jaouad L, Milochevitch C, Khalil A. PON11 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radic Res 2003; 37:77-83.
14.
Mackness B, Hine D, McElduff P, Mackness M. High C-reactive protein and lowparaoxonase1 in diabetes as risk factors for coronary heart disease. Atherosclerosis 2006; 186:396-401.
15.
Rosenblat M, Karry R, Aviram M. Paraoxonase 1 (PON11) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Atherosclerosis 2006; 187:74-81.
16.
Juretić D, Motejlkova A, Kunović B, Rekić B, Flegar-Mestrić Z, Vujić L, Mesić R, Lukac-Bajalo J, Simeon-Rudolf V. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus. Acta Pharm 2006; 56:59-68.
17.
Kocak H, Yekeler I, Basoglu A. The effect of superoxide dismutase and reduced glutathione on cardiac performance after coronary occlusion and reperfusion. In experimental study in dogs. Thrac Cardiovas Surgeon 1992; 40:140-143.
18.
Kabaroglu C, Mutaf I, Boydak B, Ozmen D, Habif S, Erdener D, Parildar Z, Bayindir O. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes. Acta Cardiol 2004; 59:606-11.
19.
Patch B, Jerudi MO, O’Neil PG. Human superoxide dismutase fails to limit infarct size after 2h ischemia and reperfusion. Circulation 1988; 78: II-373.

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com